These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3523649)

  • 21. [Effectiveness of using corvaton on patients with unstable stenocardia].
    Vakaliuk IP
    Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
    Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
    G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of angina pectoris with molsidomin: results of a double-blind study for assessment of rate of anginal attacks, exercise reaction, and systolic time intervals (author's transl)].
    Mannes GA; Goebel G; Kafka W; Rudolph W
    Herz; 1978 Jun; 3(3):172-84. PubMed ID: 363584
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the chronic antianginal effect of molsidomine.
    Dalla-Volta S; Scorzelli L; Razzolini R
    Am Heart J; 1985 Mar; 109(3 Pt 2):682-4. PubMed ID: 3883736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molsidomin in stable stress angina].
    González Juanatey JR; Amaro Cendón A; Rubio Alvarez J; Gil de la Peña M
    Med Clin (Barc); 1985 Mar; 84(10):420-1. PubMed ID: 3838784
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of molsidomine in exertion angina pectoris: double-blind, randomized and placebo-controlled study].
    Scuri PM; Gavazzi A; Falcone C; Specchia G; Montemartini C
    Cardiologia; 1987 Mar; 32(3):271-6. PubMed ID: 3607796
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of the anti-angina drug korvatone (molsidomin) and organic nitrates].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Bragina GI; Ovchinnikova LV
    Klin Med (Mosk); 1980 Aug; 58(8):55-60. PubMed ID: 6774161
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 36. [A new family of anti-angina agents].
    Gourgon R; Russo-Marie F; Nicolas G; Witchitz S; Berdeaux A; Tartulier M
    Sem Hop; 1983 Oct; 59(37-38):2627-8. PubMed ID: 6314546
    [No Abstract]   [Full Text] [Related]  

  • 37. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
    Messin R
    Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.